{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:54:58Z","timestamp":1795042498832,"version":"4.10.2"},"reference-count":39,"publisher":"Journal of Biological Methods","issue":"1","license":[{"start":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T00:00:00Z","timestamp":1740873600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HPR"],"abstract":"<jats:p>Purpose of Review\nMethadone is a synthetic opioid extensively used in opioid use disorder management but is gaining recognition for its unique pharmacological properties that make it a viable alternative for chronic pain management. This review aims to explore methadone&amp;rsquo;s pharmacokinetics, pharmacodynamics, efficacy, and safety profile to assess its potential role in managing chronic pain conditions.\n&amp;nbsp;\nRecent Findings\nMethadone&amp;rsquo;s dual action as a mu-opioid receptor agonist and NMDA receptor antagonist positions it as an effective option for managing both nociceptive and neuropathic pain. It has shown promising results in cancer pain management, refractory pain, and opioid rotation strategies. Despite its therapeutic advantages, concerns regarding its narrow therapeutic window, variable pharmacokinetics, QT interval prolongation, and risk of respiratory depression highlight the need for careful patient selection and monitoring. New evidence also sheds light on its affordability and efficacy in low-resource settings, as well as its controversial role in mitigating opioid-induced hyperalgesia.\n&amp;nbsp;\nSummary\nMethadone offers a unique therapeutic option in chronic pain management due to its multifaceted pharmacological properties. While it provides significant benefits for patients with complex pain syndromes, clinicians must exercise caution due to its safety concerns and variability in individual metabolism. A personalized approach, combined with rigorous monitoring, is essential to optimize its benefits while minimizing risks. Further research is needed to better define its role in chronic pain treatment and address unresolved safety concerns.<\/jats:p>","DOI":"10.52965\/001c.129552","type":"journal-article","created":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T14:27:48Z","timestamp":1740925668000},"page":"1","source":"Crossref","is-referenced-by-count":19,"title":["Methadone for Chronic Pain: A Review of Pharmacology, Efficacy, and Safety Concerns"],"prefix":"10.14440","volume":"13","author":[{"given":"Patrick","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa","family":"Ryder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"Valenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Phung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamal","family":"Hasoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5574","published-online":{"date-parts":[[2025,3,2]]},"reference":[{"issue":"7711","key":"ref1","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41586-018-0219-7","article-title":"Structure of the \u00b5-opioid receptor\u2013Gi protein complex","volume":"558","author":"A. Koehl","year":"2018","journal-title":"Nature"},{"key":"ref2","series-title":"StatPearls [Internet]","article-title":"Methadone","author":"M. Durrani","year":"2024"},{"issue":"3","key":"ref3","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/bph.14105","article-title":"Opioid-induced inhibition of the human 5-HT and noradrenaline transporters in vitro: Link to clinical reports of serotonin syndrome","volume":"175","author":"A. Rickli","year":"2018","journal-title":"British Journal of Pharmacology"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2165\/00003088-197601030-00004","article-title":"The relationship of pharmacokinetics to pharmacological activity: Morphine, methadone and naloxone","volume":"1","author":"B. A. Berkowitz","year":"1976","journal-title":"Clinical Pharmacokinetics"},{"key":"ref5","article-title":"Methadone Patients in Vietnam: Substance Use Patterns, Reasons for Entering Treatment, and Methadone-Related Attitudes","author":"T. H. H. Tran","year":"2023"},{"issue":"3","key":"ref6","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.jpainsymman.2017.10.017","article-title":"Methadone as a first-line opioid in cancer pain management: A systematic review","volume":"55","author":"S. Mercadante","year":"2018","journal-title":"Journal of Pain and Symptom Management"},{"issue":"2","key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003971.pub4","article-title":"Methadone for cancer pain","author":"A. B. Nicholson","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"ref8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12904-022-01076-2","article-title":"Methadone Switching for Refractory Cancer Pain","volume":"21","author":"Haiying Ding","year":"2022","journal-title":"BMC Palliative Care"},{"key":"ref9","article-title":"GoodRx Prescription Prices","author":"GoodRx","journal-title":"GoodRx"},{"issue":"3","key":"ref10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1155\/2003\/236718","article-title":"Methadone in the Treatment of Neuropathic Pain","volume":"8","author":"Bruno Gagnon","year":"2003","journal-title":"Pain Research & Management"},{"issue":"1","key":"ref11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.bja.2019.08.010","article-title":"The anaesthetist, opioid analgesic drugs, and serotonin toxicity: A mechanistic and clinical review","volume":"124","author":"B. A. Baldo","year":"2020","journal-title":"British Journal of Anaesthesia"},{"issue":"4","key":"ref12","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/01.ajp.0000125247.95213.53","article-title":"Management of Chronic Neuropathic Pain with Methadone: A Review of 13 Cases","volume":"21","author":"Nad\u00e8ge Altier","year":"2005","journal-title":"The Clinical Journal of Pain"},{"issue":"2","key":"ref13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11916-010-0171-1","article-title":"Opioid-Induced Hyperalgesia: Clinically Relevant or Extraneous Research Phenomenon?","volume":"15","author":"D. Andrew Tompkins","year":"2011","journal-title":"Current Pain and Headache Reports"},{"issue":"6","key":"ref14","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/j.1526-4637.2008.00501.x","article-title":"Improved Opioid Analgesic Effect Following Opioid Dose Reduction","volume":"9","author":"Yakov Vorobeychik","year":"2008","journal-title":"Pain Medicine (Malden, Mass.)"},{"issue":"6","key":"ref15","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/AJP.0b013e31816b2f43","article-title":"Opioid-Induced Hyperalgesia in Humans: Molecular Mechanisms and Clinical Considerations","volume":"24","author":"Larry F. Chu","year":"2008","journal-title":"The Clinical Journal of Pain"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12914","article-title":"Opioid Induced Hyperalgesia","author":"Peter Yi","year":"2015","journal-title":"Pain Medicine"},{"issue":"2","key":"ref17","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1080\/10550881003684798","article-title":"Pharmacotherapy in the Treatment of Addiction: Methadone","volume":"29","author":"Mary Jeanne Kreek","year":"2010","journal-title":"Journal of Addictive Diseases"},{"issue":"1","key":"ref18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1073\/pnas.70.1.10","article-title":"Methadone Plasma Level: Sustained by a Reservoir of Drug in Tissue","volume":"70","author":"Vincent P. Dole","year":"1973","journal-title":"Proceedings of the National Academy of Sciences - PNAS"},{"issue":"7","key":"ref19","first-page":"1353","article-title":"Methadone Treatment for Pain States","volume":"71","author":"James D. Toombs","year":"2005","journal-title":"American Family Physician"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-021-02108-9","article-title":"Intravenous methadone causes acute toxic and delayed inflammatory encephalopathy with persistent neurocognitive impairments","volume":"21","author":"J. Repple","year":"2021","journal-title":"BMC Neurology"},{"issue":"5","key":"ref21","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1002\/cpt.2717","article-title":"Identifying clinically relevant drug\u2013drug interactions with methadone and buprenorphine: A translational approach to signal detection","volume":"112","author":"T. A. Miano","year":"2022","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"3","key":"ref22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jpain.2020.04.004","article-title":"Methadone in pain management: A systematic review","volume":"22","author":"V. Hanna","year":"2021","journal-title":"The Journal of Pain"},{"issue":"26","key":"ref23","article-title":"Vital signs: Risk for overdose from methadone used for pain relief-United States, 1999-2010","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2012","journal-title":"MMWR: Morbidity & Mortality Weekly Report"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6612a2","article-title":"Methadone prescribing and overdose and the association with Medicaid preferred drug list policies\u2014United States, 2007\u20132014","volume":"66","author":"M. Faul","year":"2017","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"4","key":"ref25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jpain.2014.01.494","article-title":"Methadone safety: A clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society","volume":"15","author":"R. Chou","year":"2014","journal-title":"The Journal of Pain"},{"issue":"3","key":"ref26","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1093\/bjaceaccp\/mkv023","article-title":"The clinical use of methadone in cancer and chronic pain medicine","volume":"16","author":"J. Rajan","year":"2016","journal-title":"BJA Education"},{"key":"ref27","series-title":"The Treatment of Opioid Dependence","first-page":"59","article-title":"Pharmacology of methadone","author":"S. L. Walsh","year":"2006"},{"issue":"21","key":"ref28","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1001\/jama.2024.16954","article-title":"Buprenorphine\/Naloxone vs Methadone for the Treatment of Opioid Use Disorder","volume":"332","author":"B. Nosyk","year":"2024","journal-title":"JAMA"},{"issue":"4","key":"ref29","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1055\/s-0044-1787571","article-title":"Opioid Maintenance Therapy: A Review of Methadone, Buprenorphine, and Naltrexone Treatments for Opioid Use Disorder","volume":"44","author":"D. C. Fipps","year":"2024","journal-title":"Seminars in neurology"},{"issue":"12","key":"ref30","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s11916-023-01185-4","article-title":"Buprenorphine for Chronic Pain Management: a Narrative Review","volume":"27","author":"P. D. Vu","year":"2023","journal-title":"Current pain and headache reports"},{"issue":"1","key":"ref31","doi-asserted-by":"publisher","first-page":"27241","DOI":"10.52965\/001c.27241","article-title":"Buprenorphine for Chronic Pain: A Safer Alternative to Traditional Opioids","volume":"9","author":"S. Dalal","year":"2021","journal-title":"Health psychology research"},{"issue":"3","key":"ref32","doi-asserted-by":"publisher","first-page":"37517","DOI":"10.52965\/001c.37517","article-title":"Buprenorphine and its formulations: a comprehensive review","volume":"10","author":"S. Poliwoda","year":"2022","journal-title":"Health psychology research"},{"key":"ref33","series-title":"Chronic Pain","first-page":"599","article-title":"Chronic Diseases: An Encyclopedia of Causes, Effects, and Treatments","volume":"2","author":"A. Dydyk","year":"2024"},{"issue":"4","key":"ref34","doi-asserted-by":"publisher","first-page":"e979","DOI":"10.1097\/PR9.0000000000000979","article-title":"Use of methadone as an alternative to morphine for chronic pain management: A noninferiority retrospective observational study","volume":"6","author":"G. A. M. de Barros","year":"2021","journal-title":"Pain Reports"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11864-020-0724-4","article-title":"How to use methadone in an era of an opioid epidemic","volume":"21","author":"Y. Heung","year":"2020","journal-title":"Current Treatment Options in Oncology"},{"issue":"8","key":"ref36","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s40263-020-00743-3","article-title":"Methadone for pain management: A pharmacotherapeutic review","volume":"34","author":"D. Kreutzwiser","year":"2020","journal-title":"CNS Drugs"},{"key":"ref37","article-title":"Drug Fact Sheet: Methadone","journal-title":"Department of Justice\/ Drug Enforcement Administration"},{"issue":"4","key":"ref38","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jopan.2021.08.011","article-title":"Rediscovery of methadone to improve outcomes in pain management","volume":"37","author":"G. Lai","year":"2022","journal-title":"Journal of PeriAnesthesia Nursing"},{"issue":"6","key":"ref39","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.phrs.2004.05.002","article-title":"Methadone\u2014Metabolism, pharmacokinetics and interactions","volume":"50","author":"A. Ferrari","year":"2004","journal-title":"Pharmacological Research"}],"container-title":["Health Psychology Research"],"original-title":[],"link":[{"URL":"https:\/\/api.healthpr.org\/uploads\/file\/asp\/20250331170054728f34899.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.healthpr.org\/uploads\/file\/asp\/20250331170054728f34899.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T08:34:16Z","timestamp":1760344456000},"score":1,"resource":{"primary":{"URL":"https:\/\/healthpr.org\/journal\/HPR\/13\/1\/10.52965\/001c.129552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,2]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,6]]}},"URL":"https:\/\/doi.org\/10.52965\/001c.129552","relation":{},"ISSN":["2420-8124"],"issn-type":[{"value":"2420-8124","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,2]]}}}